SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 4 - Statement of changes in beneficial ownership of securities:
SEC Accession No. 0001104659-20-072138
Filing Date
2020-06-10
Accepted
2020-06-10 20:00:37
Documents
1
Period of Report
2020-06-08

Document Format Files

Seq Description Document Type Size
1 OWNERSHIP DOCUMENT tm2022303d2_4.html 4  
1 OWNERSHIP DOCUMENT tm2022303d2_4.xml 4 3968
  Complete submission text file 0001104659-20-072138.txt   5696
Mailing Address RIGEL PHARMACEUTICALS, INC. 1180 VETERANS BLVD. SOUTH SAN FRANCISCO CA 94080
Business Address
Maynard Ryan D (Reporting) CIK: 0001363984 (see all company filings)

Type: 4 | Act: 34 | File No.: 001-36860 | Film No.: 20955895

Mailing Address 999 SKYWAY ROAD SUITE 150 SAN CARLOS CA 94070
Business Address 999 SKYWAY ROAD SUITE 150 SAN CARLOS CA 94070 6502607120
IOVANCE BIOTHERAPEUTICS, INC. (Issuer) CIK: 0001425205 (see all company filings)

IRS No.: 753254381 | State of Incorp.: DE | Fiscal Year End: 1231
SIC: 2836 Biological Products, (No Diagnostic Substances)